JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1997) 154, 75-84       DOI: 10.1677/joe.0.1540075
© 1997 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rider, V
Right arrow Articles by Foster, R T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rider, V
Right arrow Articles by Foster, R T

Oestrogen and progesterone control basic fibroblast growth factor mRNA in the rat uterus

V Rider, D L Carlone and R T Foster

Cell proliferation and differentiation in the rodent uterus are probably controlled by the interaction of female sex steroids with polypeptide growth factors. Uterine basic fibroblast growth factor (bFGF) mRNA was measured by RNase protection during the time (days 2–4) of endometrial cell proliferation in the pregnant rat. bFGF transcripts were detected at each of the 3 days of pregnancy examined. To investigate the influence of oestrogen and progesterone on bFGF mRNA accumulation, ovariectomized rats were treated with oestradiol for 48 h followed by a single injection of oestradiol, progesterone, the two steroids co-injected or oil vehicle alone. Uterine RNA was collected 6 h after the last hormone injection. Steroid treatments increased steady-state uterine bFGF mRNA compared with vehicle control animals as measured by RNase protection. Northern blot analysis of c-fos and c-jun mRNAs from these same treatment groups revealed increased protooncogene expression in the uterus of hormone treated rats compared with the control animals. Temporal analysis of bFGF mRNA in ovariectomized rats at 1, 3 and 6 h after acute oestrogen and oestrogen-progesterone co-administration showed a dual pattern of transcript accumulation. Both hormone treatments increased bFGF mRNA within 1 h compared with vehicle injected rats. Co-administration of the two hormones, however, repressed bFGF mRNA accumulation relative to oestrogen at 3 and 6 h. Together, these studies provide evidence that bFGF control of uterine cell proliferation in pregnant rats can occur from newly synthesized bFGF. Moreover, the results suggest that progesterone is a potent stimulator of bFGF expression in the uterus.

Journal of Endocrinology (1997) 154, 75–84




This article has been cited by other articles:


Home page
EndocrinologyHome page
D. D. Michael, I. M. Alvarez, O. M. Ocon, A. M. Powell, N. C. Talbot, S. E. Johnson, and A. D. Ealy
Fibroblast Growth Factor-2 Is Expressed by the Bovine Uterus and Stimulates Interferon-{tau} Production in Bovine Trophectoderm
Endocrinology, July 1, 2006; 147(7): 3571 - 3579.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Cotton, G. M. Gibbs, L. G. Sanchez-Partida, J. R. Morrison, D. M. de Kretser, and M. K. O'Bryan
FGFR-1 signaling is involved in spermiogenesis and sperm capacitation
J. Cell Sci., January 1, 2006; 119(1): 75 - 84.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Dabrosin
Positive Correlation between Estradiol and Vascular Endothelial Growth Factor but not Fibroblast Growth Factor-2 in Normal Human Breast Tissue In vivo
Clin. Cancer Res., November 15, 2005; 11(22): 8036 - 8041.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Dabrosin
Variability of Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo during the Menstrual Cycle
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2695 - 2698.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
V. Rider, S. R. Jones, R. T. Foster, and K. Imakawa
Changes in the Temporal and Spatial Expression of H{beta}58 During Formation and Maturation of the Chorioallantoic Placenta in the Rat
Biol Reprod, December 1, 2000; 63(6): 1735 - 1746.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. R. Jones, B. F. Kimler, W. M. Justice, and V. Rider
Transit of Normal Rat Uterine Stromal Cells through G1 Phase of the Cell Cycle Requires Progesterone-Growth Factor Interactions
Endocrinology, February 1, 2000; 141(2): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. M. Hyder and G. M. Stancel
Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and Progestins
Mol. Endocrinol., June 1, 1999; 13(6): 806 - 811.
[Full Text]


Home page
CirculationHome page
Y. K. Hodges, J. K. Richer, K. B. Horwitz, and L. D. Horwitz
Variant Estrogen and Progesterone Receptor Messages in Human Vascular Smooth Muscle
Circulation, May 25, 1999; 99(20): 2688 - 2693.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.J. Peluso and A. Pappalardo
Progesterone Maintains Large Rat Granulosa Cell Viability Indirectly by Stimulating Small Granulosa Cells to Synthesize Basic Fibroblast Growth Factor
Biol Reprod, February 1, 1999; 60(2): 290 - 296.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
V. Rider, B. F. Kimler, and W. M. Justice
Progesterone-Growth Factor Interactions in Uterine Stromal Cells
Biol Reprod, July 1, 1998; 59(3): 464 - 469.
[Full Text]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Society for Endocrinology.